BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like Merck & Co. is Looking to Hire Many Scientists at BIO in San Diego May 22, 2017 Actinium Highlights Presence At Upcoming Annual Meeting June 7, 2017 Ascendis Announces Pricing Of Public Offering Of ADSs September 26, 2017
